Adam Maeder
Stock Analyst at Piper Sandler
(4.51)
# 1,018
Out of 4,417 analysts
346
Total ratings
53.3%
Success rate
10.5%
Average return
Main Sectors:
Stocks Rated by Adam Maeder
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ISRG Intuitive Surgical | Reiterated: Buy | $580 | $417.07 | +39.07% | 49 | Jun 2, 2026 | |
| ABT Abbott Laboratories | Maintained: Buy | $115 | $90.62 | +26.90% | 17 | May 29, 2026 | |
| GKOS Glaukos | Reiterated: Buy | $165 | $127.53 | +29.38% | 15 | May 22, 2026 | |
| STAA STAAR Surgical Company | Maintained: Hold | $16 → $33 | $28.92 | +14.11% | 5 | May 14, 2026 | |
| STXS Stereotaxis | Reiterated: Buy | $4 → $3.5 | $1.82 | +92.31% | 18 | May 13, 2026 | |
| NYXH Nyxoah | Reiterated: Buy | $9 → $7 | $1.58 | +343.04% | 24 | May 13, 2026 | |
| SGHT Sight Sciences | Reiterated: Buy | $9 | $5.02 | +79.28% | 8 | May 7, 2026 | |
| RXST RxSight | Maintained: Hold | $10 | $4.68 | +113.90% | 8 | May 7, 2026 | |
| RMD ResMed | Maintained: Hold | $275 → $233 | $193.94 | +20.14% | 7 | May 6, 2026 | |
| EW Edwards Lifesciences | Maintained: Buy | $100 | $88.58 | +12.89% | 55 | May 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $42 | $26.43 | +58.91% | 25 | May 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $85 → $55 | $41.39 | +32.88% | 49 | May 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $5.5 → $3 | $1.20 | +150.00% | 13 | Apr 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $85 | $79.48 | +6.95% | 32 | Feb 19, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $8.5 → $7 | $0.25 | +2,700.00% | 12 | Aug 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $4 | $0.7124 | +461.48% | 6 | Aug 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $74 | $34.95 | n/a | 1 | Apr 9, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $3.50 → $2.10 | $0.26 | n/a | 2 | Dec 23, 2019 |
Intuitive Surgical
Jun 2, 2026
Reiterated: Buy
Price Target: $580
Current: $417.07
Upside: +39.07%
Abbott Laboratories
May 29, 2026
Maintained: Buy
Price Target: $115
Current: $90.62
Upside: +26.90%
Glaukos
May 22, 2026
Reiterated: Buy
Price Target: $165
Current: $127.53
Upside: +29.38%
STAAR Surgical Company
May 14, 2026
Maintained: Hold
Price Target: $16 → $33
Current: $28.92
Upside: +14.11%
Stereotaxis
May 13, 2026
Reiterated: Buy
Price Target: $4 → $3.5
Current: $1.82
Upside: +92.31%
Nyxoah
May 13, 2026
Reiterated: Buy
Price Target: $9 → $7
Current: $1.58
Upside: +343.04%
Sight Sciences
May 7, 2026
Reiterated: Buy
Price Target: $9
Current: $5.02
Upside: +79.28%
RxSight
May 7, 2026
Maintained: Hold
Price Target: $10
Current: $4.68
Upside: +113.90%
ResMed
May 6, 2026
Maintained: Hold
Price Target: $275 → $233
Current: $193.94
Upside: +20.14%
Edwards Lifesciences
May 5, 2026
Maintained: Buy
Price Target: $100
Current: $88.58
Upside: +12.89%
May 5, 2026
Reiterated: Buy
Price Target: $42
Current: $26.43
Upside: +58.91%
May 5, 2026
Downgraded: Hold
Price Target: $85 → $55
Current: $41.39
Upside: +32.88%
Apr 7, 2026
Maintained: Buy
Price Target: $5.5 → $3
Current: $1.20
Upside: +150.00%
Feb 19, 2026
Reiterated: Buy
Price Target: $85
Current: $79.48
Upside: +6.95%
Aug 13, 2025
Maintained: Hold
Price Target: $8.5 → $7
Current: $0.25
Upside: +2,700.00%
Aug 1, 2025
Maintained: Buy
Price Target: $4
Current: $0.7124
Upside: +461.48%
Apr 9, 2020
Initiated Coverage: Buy
Price Target: $74
Current: $34.95
Upside: n/a
Dec 23, 2019
Reiterated: Buy
Price Target: $3.50 → $2.10
Current: $0.26
Upside: n/a